AULIN SHERRY

CIK 00018621441 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001862144

Recent Transactions

24 trades

Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-12-18−16,000→ 6,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-12-18$41.28/sh−2,135→ 7,199 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-12-18−9,334→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-12-18$41.19/sh−11,510→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-12-18$41.23/sh−7,199→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-12-18$11.58/sh+16,000→ 16,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-12-18$41.28/sh−4,490→ 11,510 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-12-18$9.44/sh+9,334→ 9,334 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-11+100,000→ 100,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-10+120,000→ 120,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-09-02−9,000→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-09-02−2,292→ 0 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-02$39.53/sh−3,293→ 15,355 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-02$39.57/sh−15,355→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-09-02−813→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-02$9.44/sh+9,000→ 9,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-02$3.10/sh+2,292→ 12,137 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-09-02−32→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-09-02−6,511→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-02$7.49/sh+32→ 9,032 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-02$8.40/sh+813→ 9,845 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-02$4.75/sh+6,511→ 18,648 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-10+125,000→ 125,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-06-03+100,000→ 100,000 total

Companies

Xenon Pharmaceuticals Inc.
Chief Financial Officer
$XENE

Recent Filings

Address

200 - 3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov